Cancer Cachexia Market Share

North America Market Forecast

North America cancer cachexia market is expected to hold largest revenue share of about 30% during the forecast period. The market for cancer cachexia is dominated by North America due to the region's rising prevalence of chronic illnesses like cancer and expanding knowledge of cachexia treatments. The availability of treatment choices and growing healthcare costs will also accelerate the market's development pace in this region. North America is anticipated to lead the market because of the region's high cancer and cancer cachexia rates, abundance of pharmaceutical companies, and evolving approaches to cancer patient treatment. Mexico is estimated to have about 195,499 new cases of cancer, based on a survey in 2020. In addition, the American Cancer Society 2022 projects that there will be 1.9 million new cancer diagnoses in the US in 2022.

APAC Market Statistics

Cancer cachexia market in the Asia Pacific is predicted to account for 27% of the revenue share by the end of 2037. The growth of the market is because this area is home to generic producers. Additionally, the expansion of government initiatives and the construction of healthcare infrastructure will accelerate the growth rate of this market in this region.